Acadia Pharmaceuticals Inc
ACAD - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.55B
Close$
$-10.16
147.3% downside
Current Fair Value
147.3% downsideOvervalued by 147.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.55 Billion |
|---|---|
| Enterprise Value | $3.24 Billion |
| Earnings per Share | $2.32 |
| Beta | 0.89 |
| Outstanding Shares | 171,603,000 |
Return
| Return on Equity | 29.12% |
|---|---|
| Return on Assets | 21.83% |
| Return on Invested Capital | 6.27% |
Valuation & Multiples
| P/E Ratio | 9.15 |
|---|---|
| PEG | 50.48 |
| Price to Sales | 3.58 |
| Price to Book Ratio | 3.07 |
| Enterprise Value to Revenue | 2.84 |
| Enterprise Value to EBIT | 37.35 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS Estimate
$0.20
Consensus analyst estimateRevenue Estimate
$332.58 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 100.08% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.05%▼ 97.95% |
|---|---|
| Total Invested | $36.48M▼ 99.15% |
| Investors Holding | 86▼ 279.00% |
About Acadia Pharmaceuticals Inc
CEO: Uli Hacksell
